Kwangdong's B hepatitis vaccine to be cancelled.

The product registration of Biken HB injection, a gene recombinant type of B hepatitis vaccine of Kwangdong pharm. co. has been cancelled in a KFDA's administrative measure because of no compliance to the product review.

The KFDA said that Kwangdong had never imported Biken HB injection nor submitted any review data provisionally required. The company did not raise any appeals against the KF...